| 37480150 | Anti-carbamylated protein antibodies in systemic sclerosis. | | 2023 |
| 36418483 | Glycobiology of rheumatic diseases. | Nature reviews. Rheumatology | 2023 |
| 36403538 | Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis. | Seminars in Arthritis and Rheumatism | 2023 |
| 37725442 | Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts. | | 2023 |
| 37788903 | IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis. | | 2023 |
| 38053459 | Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association. | | 2023 |
| 37862070 | Effect of Antigen Valency on Autoreactive B-Cell Targeting. | | 2023 |
| 36716825 | Differences in IgG autoantibody Fab glycosylation across autoimmune diseases. | | 2023 |
| 37209914 | Addressing the key issue: Antigen-specific targeting of B cells in autoimmune diseases. | | 2023 |
| 36890568 | Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations. | | 2023 |
| 36823186 | Author Correction: Glycobiology of rheumatic diseases. | | 2023 |
| 36754962 | A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. | | 2023 |
| 37066741 | Tramadol/paracetamol treatment attenuates the development of collagen antibody-induced arthritis and interferes with prednisolone treatment in mice. | | 2023 |
| 36480251 | IgG Fab Glycans Hinder FcRn-Mediated Placental Transport. | | 2023 |
| 36746531 | Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies. | | 2023 |
| 37306812 | Spondyloarthritis mass cytometry immuno-monitoring: a proof of concept study in the tight-control and treat-to target TiCoSpA trial. | | 2023 |
| 37507206 | Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis. | | 2023 |
| 37498177 | A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners. | | 2023 |
| 35138894 | Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation. | Science advances | 2022 |
| 36371234 | Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial. | Trials | 2022 |
| 35459696 | Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis. | Annals of the Rheumatic Diseases | 2022 |
| 35705253 | At Critically Low Antigen Densities, IgM Hexamers Outcompete Both IgM Pentamers and IgG1 for Human Complement Deposition and Complement-Dependent Cytotoxicity. | Journal of Immunology | 2022 |
| 36229887 | Absence of Epstein-Barr virus DNA in anti-citrullinated protein antibody-expressing B cells of patients with rheumatoid arthritis. | | 2022 |
| 36336400 | Comprehensive overview of autoantibody isotype and subclass distribution. | Journal of Allergy and Clinical Immunology | 2022 |
| 36278483 | Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis. | JCI Insight | 2022 |
| 35416963 | In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis. | Rheumatology | 2022 |
| 36197299 | Comparative Photoaffinity Profiling of Omega-3 Signaling Lipid Probes Reveals Prostaglandin Reductase 1 as a Metabolic Hub in Human Macrophages. | Journal of the American Chemical Society | 2022 |
| 35606567 | From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. | Nature reviews. Rheumatology | 2022 |
| 35855325 | Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data. | NAR Genomics and Bioinformatics | 2022 |
| 34285049 | Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis. | Ann Rheum Dis | 2022 |
| 35259296 | Multifunctional, Multivalent PIC Polymer Scaffolds for Targeting Antigen-Specific, Autoreactive B Cells. | ACS Biomaterials Science and Engineering | 2022 |
| 35188715 | IgG Anti-Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross-Sectional Study Encompassing ~1,500 Samples. | Arthritis and Rheumatology | 2022 |
| 34385139 | Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA. | Annals of the Rheumatic Diseases | 2022 |
| 34998422 | Hyaluronidase treatment of synovial fluid is required for accurate detection of inflammatory cells and soluble mediators. | | 2022 |
| 34876234 | Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications. | | 2021 |
| 32482649 | Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis. | Journal of Rheumatology | 2021 |
| 33784344 | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis. | PLoS ONE | 2021 |
| 34212151 | Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens. | RSC Chemical Biology | 2021 |
| 34042326 | Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis. | Arthritis and Rheumatology | 2021 |
| 33648960 | Onset of rheumatoid arthritis after COVID-19: coincidence or connected? | Annals of the Rheumatic Diseases | 2021 |
| 32594174 | Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines). | Rheumatology | 2021 |
| 33144303 | Do autoantibody-responses mature between presentation with arthralgia suspicious for progression to rheumatoid arthritis and development of clinically apparent inflammatory arthritis? A longitudinal serological study. | Annals of the Rheumatic Diseases | 2021 |
| 32896247 | Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls. | Clinical and Experimental Rheumatology | 2021 |
| 34715910 | Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA status. | | 2021 |
| 34479638 | Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load. | | 2021 |
| 31409590 | Response to: "How to communicate in science" by Klareskog . | Annals of the Rheumatic Diseases | 2020 |
| 32133009 | A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma. | Frontiers in Immunology | 2020 |
| 31634584 | Complement component C1q is produced by isolated articular chondrocytes. | Osteoarthritis and Cartilage | 2020 |
| 32041746 | Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. | Annals of the Rheumatic Diseases | 2020 |
| 32276504 | Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses. | Cells | 2020 |